← Open Payments lookup

NPI 1740945351: Open Payments

NPI 1740945351. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$202 in 8 payments from 5 companies in 2025. Trend: 2023 $519 · 2024 $850 · 2025 $202

Food & beverage: $202
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$32
Janssen Pharmaceuticals, Inc1$28
ABBVIE INC.1$21
Teva Pharmaceuticals USA, Inc.1$15

Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, UZEDY.